Columbia neurologist Denise Chou, MD, explains a new breakthrough in headache medicine: the first targeted preventive therapy for migraine.
Wayne Frankel, the newest member of the Institute for Genomic Medicine, says recent advances in gene discovery and editing are illuminating epilepsy.
A study offers an opportunity to highlight a number of important, ongoing developments in the field of concussion and CTE.
Increased connectivity in the brain's default mode network is a potential precursor, or biomarker, indicating a risk of developing major depressive disorder.
A drug that boosts activity in the brain’s “garbage disposal” system can decrease levels of toxic proteins associated with Alzheimer’s disease and other neurodegenerative disorders and improve cognition in mice.
P&S researcher Dritan Agalliu, PhD, finds pathway by which recurrent strep infections may lead to autoimmune psychiatric disorders.